Artificial Pancreas Devices Systems - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB503246736

Publication Date:

March 18, 2024

Pages:

105

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."

An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The global market for Artificial Pancreas Devices Systems was estimated to be worth US$ 89 million in 2023 and is forecast to a readjusted size of US$ 199.8 million by 2030 with a CAGR of 12.1% during the forecast period 2024-2030
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Pancreas Devices Systems, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Artificial Pancreas Devices Systems by region & country, by Type, and by Application.
The Artificial Pancreas Devices Systems market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Pancreas Devices Systems.
麻豆原创 Segmentation
By Company
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Segment by Type:
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Artificial Pancreas Devices Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Artificial Pancreas Devices Systems in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Artificial Pancreas Devices Systems Product Introduction
1.2 Global Artificial Pancreas Devices Systems 麻豆原创 Size Forecast
1.2.1 Global Artificial Pancreas Devices Systems Sales Value (2019-2030)
1.2.2 Global Artificial Pancreas Devices Systems Sales Volume (2019-2030)
1.2.3 Global Artificial Pancreas Devices Systems Sales Price (2019-2030)
1.3 Artificial Pancreas Devices Systems 麻豆原创 Trends & Drivers
1.3.1 Artificial Pancreas Devices Systems Industry Trends
1.3.2 Artificial Pancreas Devices Systems 麻豆原创 Drivers & Opportunity
1.3.3 Artificial Pancreas Devices Systems 麻豆原创 Challenges
1.3.4 Artificial Pancreas Devices Systems 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Pancreas Devices Systems Players Revenue Ranking (2023)
2.2 Global Artificial Pancreas Devices Systems Revenue by Company (2019-2024)
2.3 Global Artificial Pancreas Devices Systems Players Sales Volume Ranking (2023)
2.4 Global Artificial Pancreas Devices Systems Sales Volume by Company Players (2019-2024)
2.5 Global Artificial Pancreas Devices Systems Average Price by Company (2019-2024)
2.6 Key Manufacturers Artificial Pancreas Devices Systems Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Artificial Pancreas Devices Systems Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Artificial Pancreas Devices Systems
2.9 Artificial Pancreas Devices Systems 麻豆原创 Competitive Analysis
2.9.1 Artificial Pancreas Devices Systems 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Artificial Pancreas Devices Systems Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Pancreas Devices Systems as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Threshold Suspended Device Systems
3.1.2 Hybrid Closed-loop APDS
3.1.3 Other Systems
3.2 Global Artificial Pancreas Devices Systems Sales Value by Type
3.2.1 Global Artificial Pancreas Devices Systems Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Artificial Pancreas Devices Systems Sales Value, by Type (2019-2030)
3.2.3 Global Artificial Pancreas Devices Systems Sales Value, by Type (%) (2019-2030)
3.3 Global Artificial Pancreas Devices Systems Sales Volume by Type
3.3.1 Global Artificial Pancreas Devices Systems Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Artificial Pancreas Devices Systems Sales Volume, by Type (2019-2030)
3.3.3 Global Artificial Pancreas Devices Systems Sales Volume, by Type (%) (2019-2030)
3.4 Global Artificial Pancreas Devices Systems Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Artificial Pancreas Devices Systems Sales Value by Application
4.2.1 Global Artificial Pancreas Devices Systems Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Pancreas Devices Systems Sales Value, by Application (2019-2030)
4.2.3 Global Artificial Pancreas Devices Systems Sales Value, by Application (%) (2019-2030)
4.3 Global Artificial Pancreas Devices Systems Sales Volume by Application
4.3.1 Global Artificial Pancreas Devices Systems Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Artificial Pancreas Devices Systems Sales Volume, by Application (2019-2030)
4.3.3 Global Artificial Pancreas Devices Systems Sales Volume, by Application (%) (2019-2030)
4.4 Global Artificial Pancreas Devices Systems Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Artificial Pancreas Devices Systems Sales Value by Region
5.1.1 Global Artificial Pancreas Devices Systems Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Artificial Pancreas Devices Systems Sales Value by Region (2019-2024)
5.1.3 Global Artificial Pancreas Devices Systems Sales Value by Region (2025-2030)
5.1.4 Global Artificial Pancreas Devices Systems Sales Value by Region (%), (2019-2030)
5.2 Global Artificial Pancreas Devices Systems Sales Volume by Region
5.2.1 Global Artificial Pancreas Devices Systems Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Artificial Pancreas Devices Systems Sales Volume by Region (2019-2024)
5.2.3 Global Artificial Pancreas Devices Systems Sales Volume by Region (2025-2030)
5.2.4 Global Artificial Pancreas Devices Systems Sales Volume by Region (%), (2019-2030)
5.3 Global Artificial Pancreas Devices Systems Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Artificial Pancreas Devices Systems Sales Value, 2019-2030
5.4.2 North America Artificial Pancreas Devices Systems Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Artificial Pancreas Devices Systems Sales Value, 2019-2030
5.5.2 Europe Artificial Pancreas Devices Systems Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Artificial Pancreas Devices Systems Sales Value, 2019-2030
5.6.2 Asia Pacific Artificial Pancreas Devices Systems Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Artificial Pancreas Devices Systems Sales Value, 2019-2030
5.7.2 South America Artificial Pancreas Devices Systems Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Artificial Pancreas Devices Systems Sales Value, 2019-2030
5.8.2 Middle East & Africa Artificial Pancreas Devices Systems Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Pancreas Devices Systems Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Artificial Pancreas Devices Systems Sales Value
6.2.1 Key Countries/Regions Artificial Pancreas Devices Systems Sales Value, 2019-2030
6.2.2 Key Countries/Regions Artificial Pancreas Devices Systems Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Artificial Pancreas Devices Systems Sales Value, 2019-2030
6.3.2 United States Artificial Pancreas Devices Systems Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Artificial Pancreas Devices Systems Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Artificial Pancreas Devices Systems Sales Value, 2019-2030
6.4.2 Europe Artificial Pancreas Devices Systems Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Artificial Pancreas Devices Systems Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Artificial Pancreas Devices Systems Sales Value, 2019-2030
6.5.2 China Artificial Pancreas Devices Systems Sales Value by Type (%), 2023 VS 2030
6.5.3 China Artificial Pancreas Devices Systems Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Artificial Pancreas Devices Systems Sales Value, 2019-2030
6.6.2 Japan Artificial Pancreas Devices Systems Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Artificial Pancreas Devices Systems Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Artificial Pancreas Devices Systems Sales Value, 2019-2030
6.7.2 South Korea Artificial Pancreas Devices Systems Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Artificial Pancreas Devices Systems Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Pancreas Devices Systems Sales Value, 2019-2030
6.8.2 Southeast Asia Artificial Pancreas Devices Systems Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Artificial Pancreas Devices Systems Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Artificial Pancreas Devices Systems Sales Value, 2019-2030
6.9.2 India Artificial Pancreas Devices Systems Sales Value by Type (%), 2023 VS 2030
6.9.3 India Artificial Pancreas Devices Systems Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Medtronic Artificial Pancreas Devices Systems Product Offerings
7.1.5 Medtronic Recent Development
7.2 Bigfoot Biomedical
7.2.1 Bigfoot Biomedical Company Information
7.2.2 Bigfoot Biomedical Introduction and Business Overview
7.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Offerings
7.2.5 Bigfoot Biomedical Recent Development
7.3 Beta Bionics
7.3.1 Beta Bionics Company Information
7.3.2 Beta Bionics Introduction and Business Overview
7.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Offerings
7.3.5 Beta Bionics Recent Development
7.4 Admetsys
7.4.1 Admetsys Company Information
7.4.2 Admetsys Introduction and Business Overview
7.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Admetsys Artificial Pancreas Devices Systems Product Offerings
7.4.5 Admetsys Recent Development
7.5 Insulet
7.5.1 Insulet Company Information
7.5.2 Insulet Introduction and Business Overview
7.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Insulet Artificial Pancreas Devices Systems Product Offerings
7.5.5 Insulet Recent Development
7.6 Tandem Diabetes Care
7.6.1 Tandem Diabetes Care Company Information
7.6.2 Tandem Diabetes Care Introduction and Business Overview
7.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Offerings
7.6.5 Tandem Diabetes Care Recent Development
7.7 Defymed
7.7.1 Defymed Company Information
7.7.2 Defymed Introduction and Business Overview
7.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Defymed Artificial Pancreas Devices Systems Product Offerings
7.7.5 Defymed Recent Development
8 Industry Chain Analysis
8.1 Artificial Pancreas Devices Systems Industrial Chain
8.2 Artificial Pancreas Devices Systems Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Pancreas Devices Systems Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Pancreas Devices Systems Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.